SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 16,056.24 |
Enterprise Value ($M) | 16,397.20 |
Book Value ($M) | 5,073.82 |
Book Value / Share | 26.72 |
Price / Book | 3.16 |
NCAV ($M) | 1,186.15 |
NCAV / Share | 6.25 |
Price / NCAV | 13.54 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.03 |
Return on Equity (ROE) | 0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.70 |
Current Ratio | 2.74 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2,985.01 |
Assets | 6,872.67 |
Liabilities | 1,798.86 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 2,419.23 |
Operating Income | 171.60 |
Net Income | 167.65 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 159.26 |
Cash from Investing | -111.24 |
Cash from Financing | -18.73 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 10.00 | 5.23 | |
13G/A | BlackRock Inc. | 12.00 | 54.53 | |
13G/A | Dodge & Cox | 7.40 | -2.71 | |
13G/A | Primecap Management Co/ca/ | 9.78 | 4.74 | |
13G | Capital Research Global Investors | 5.70 | 90.67 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
122,754 | 779,384 | 15.75 | |
481,506 | 1,618,290 | 29.75 | |
88,784 | 501,404 | 17.71 | |
112,310 | 701,248 | 16.02 | |
145,635 | 782,256 | 18.62 | |
(click for more detail) |
Similar Companies | |
---|---|
BIIB – Biogen Inc. | BLUE – bluebird bio, Inc. |
BMEA – Biomea Fusion, Inc. | BOLT – Bolt Biotherapeutics, Inc. |
BPMC – Blueprint Medicines Corporation |
Financial data and stock pages provided by
Fintel.io